Mick van Eijs

Postdoc - medical

Biography

Current positions:

2025-current AIOS internal medicine, Meander Medisch Centrum Amersfoort

2025-current Postdoc onco-immunology, UMC Utrecht

Former positions:

2024-2025 ANIOS internal medicine, St. Antonius Ziekenhuis Nieuwegein

2020-2024 PhD candidate onco-immunology, UNICIT study: UNICIT - UMC Utrecht

More info on our research

Education:

2016-2020 Medicine (MD), Utrecht University

2017-2018 Health Economics, Policy and Law (MSc), Erasmus University Rotterdam

2013-2016 Medicine (BSc), Utrecht University

Contact

meijs2@umcutrecht.nl

Pure profile

Recent publications

All publications

Blood and tissue correlates of steroid non-response in checkpoint inhibition-induced immune-related adverse events Mick J M van Eijs, M Marlot van der Wal, Hedi-Britt Klotškova, Noël M M Dautzenberg, Mark Schuiveling, Rik J Verheijden, Fiona D M van Schaik, Bas Oldenburg, Stefan Nierkens, Karijn P M Suijkerbuijk, Femke van Wijk,
Communications medicine, 2025, vol. 5, p.1-14

Giving color to immune checkpoint inhibition’s darker side Mick van Eijs
2025

Gut microbiome and immune checkpoint inhibitor toxicity Rik J Verheijden, Mick J M van Eijs, Fernanda L Paganelli, Marco C Viveen, Malbert R C Rogers, Janetta Top, Anne M May, Janneke H H M van de Wijgert, Karijn P M Suijkerbuijk,
European Journal of Cancer, 2025, vol. 216

Corticosteroids and other immunosuppressants for immune-related adverse events and checkpoint inhibitor effectiveness in melanoma Rik J. Verheijden, Femke H. Burgers, Josephine C. Janssen, Anouk E. Putker, Sophie P.G.R. Veenstra, Geke A.P. Hospers, Maureen J.B. Aarts, Karel W. Hehenkamp, Veerle L.E. Doornebosch, Marthe Verhaert, Franchette W.P.J. van den Berkmortel, Katerina Chatzidionysiou, Arturo Llobell, Milton Barros, Alexandre T.J. Maria, Akari Takeji, José Salvador García Morillo, Merav Lidar, Mick J.M. van Eijs, Christian U. Blank, Sandrine Aspeslagh, Djura Piersma, Ellen Kapiteijn, Mariette Labots, Marye J. Boers-Sonderen, Astrid A.M. van der Veldt, John B.A.G. Haanen, Anne M. May, Karijn P.M. Suijkerbuijk
European Journal of Cancer, 2024, vol. 207

Clinical and translational attributes of immune-related adverse events Karijn P M Suijkerbuijk, Mick J M van Eijs, Femke van Wijk, Alexander M M Eggermont
Nature Cancer, 2024, vol. 5, p.557-571

Physical activity and checkpoint inhibition Rik J Verheijden, Anna Cabané Ballester, Karel C Smit, Mick J M van Eijs, Cheryl P Bruijnen, Anne S R van Lindert, Karijn P M Suijkerbuijk, Anne M May
Journal of the National Cancer Institute, 2023, vol. 116, p.573-579